Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
about
Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applicationsVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmIntravenously administered nanoparticles increase survival following blast trauma.Platelet substitutes and novel platelet products.Novel treatment modalities: new platelet preparations and substitutes.Substitutes and alternatives to platelet transfusions in thrombocytopenic patients.Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide.Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity.Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan.Thrombocytopenia-Platelet Support or Growth Factors?Alternatives to allogeneic platelet transfusion.In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.Alternatives to standard blood transfusion: availability and promise.Revisitation of the clinical indications for the transfusion of platelet concentrates.Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries.Synthetic Strategies for Engineering Intravenous Hemostats.Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C.Intravenous hemostats: challenges in translation to patientsHemostatic strategies for traumatic and surgical bleeding.Bio-inspired nanomedicine strategies for artificial blood components.Airflow-directed in situ electrospinning of a medical glue of cyanoacrylate for rapid hemostasis in liver resection.Intravenous hemostatic nanoparticles increase survival following blunt trauma injury.Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels
P2860
Q26829998-018045F0-7742-41EE-A1E7-B6BA5E0EB8AAQ27026630-5900EF1E-3642-410E-9E10-64C0EBB47634Q30584438-07A7B70A-2DA2-4488-8C28-1D9F0558C397Q33334939-D21144F9-49CA-40FD-B9BD-5B4C4D398ED6Q33338937-3DC696EE-D51B-4B09-85C8-889831C1DE4DQ33349074-2E59DAD9-2091-4BE1-8760-80CE66F1E9B3Q33367016-FAD85C2C-586B-40D4-A042-FEB1D6769ECDQ33375630-1C555140-5AF3-4EEE-86CC-1E43EAB49385Q33401554-D49F3F6F-7413-4D24-808B-F06B6F1687F8Q33402878-4E6FDCB9-1DB0-496D-A2C4-4738DB885E27Q33433352-6E67E503-D292-4B67-8C2E-1560A9EFAB40Q33433930-B621F8A0-7C47-4861-B645-187E6A90FDD6Q33435484-7286E0EA-1895-4805-9977-04397B475BF3Q33437439-B54BC47A-2EDB-405A-A2F0-CEDA1BC27F2FQ33785932-37173541-07CA-4253-912A-C6225B22723AQ34434805-E80AD2A6-4EBC-4065-BFC6-68B044A754E4Q34579964-AD6057A3-5870-41DD-BD78-0274C71ADD52Q35858739-B8581EF6-7560-45A8-93EB-F9E88170DF2FQ36647460-51E3064F-4276-466A-813F-383B3312424DQ37278074-4AC306B0-746C-4D7D-998A-21871D2D1B85Q38148673-0D24F04B-89BF-48FB-BD20-EEA7FC8D0BCCQ38168784-80E64A8B-8B71-4152-B0F6-163068ACD6F0Q39179984-9559C462-C7BA-41F0-A927-30F41DEE0D54Q39190309-7093290B-6015-4F5D-BFE2-01D9371ADAA3Q41215308-83549307-6096-4A47-B729-E42CFA76312FQ42579276-7DBD45CE-A961-4FAF-879F-F24BC57FF50AQ45868696-37D19581-A9C0-4EC5-AD0F-27D5083B869BQ47324534-186B0098-213A-4F08-8D72-036B5D5381D6Q56365154-746B0075-A40D-48D3-AAB1-9AFEB4E61FB9
P2860
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@ast
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@en
type
label
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@ast
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@en
prefLabel
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@ast
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@en
P2093
P356
P1433
P1476
Fibrinogen-coated albumin micr ...... rely thrombocytopenic rabbits.
@en
P2093
Biemond BJ
Friederich PW
Heijnen HF
Middleton S
de Groot PG
ten Cate JW
P2888
P304
P356
10.1038/4795
P407
P577
1999-01-01T00:00:00Z